Rapport Therapeutics Inc (RAPP)
$25.05 +3.47% Close Oct 30, 2026 Live
Rapport Therapeutics stock today
Rapport Therapeutics closed at $25.05 on October 30, 2026, up 3.47% on the day. Over the past year it returned -6.8% with dividends reinvested, against +12.4% for the S&P 500. Its market value is $1.20 billion.
$30.00$40.00$50.00
NovJan 2026MarMayJulSep
| Period | RAPP | S&P 500 (SPY) |
|---|---|---|
| 1 month | -25.4% | -0.9% |
| 3 months | -41.4% | +2.1% |
| Year to date | -17.4% | +11.7% |
| 1 year | -6.8% | +12.4% |
Key statistics
- Market value
- $1.20B
- Price / sales
- 59.9
- 52-week range
- $22.50 to $52.50
- Next report
- Nov 5, 2026 (estimated)
About Rapport Therapeutics
Develops therapeutic treatments for rare and serious diseases.
Sector: Health Care
More on Rapport Therapeutics
- Returns: what $1,000 became$1,000 one year ago is $931.92 today
No forecast, no recommendation. This page describes Rapport Therapeutics Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.